Literature DB >> 30451150

Expert opinion on managing chronic HCV in patients with neuropsychiatric manifestations.

Daniel Forton1,2, Karin Weissenborn3, Mark Bondin4, Patrice Cacoub5,6,7,8.   

Abstract

Neurological manifestations of HCV infection appear to be under-recognized in clinical practice despite the majority of HCV-infected patients experiencing symptoms such as fatigue, depression and cognitive dysfunction. There is also growing evidence for a link between HCV infection and an increased risk of Parkinson's disease. The mechanism underpinning the association between HCV and these neuropsychiatric syndromes still requires further investigation. Here we review the pre-clinical and clinical evidence for a link between HCV and effects on the central nervous system leading to neuropsychiatric syndromes. Lastly, we describe how improvements in neuropsychiatric manifestations of HCV following treatment have been observed, which is subsequently reflected in an overall improvement in health-related quality of life.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30451150     DOI: 10.3851/IMP3245

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


  2 in total

1.  Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders.

Authors:  Nicolò de Gennaro; Lucia Diella; Laura Monno; Gioacchino Angarano; Michele Milella; Annalisa Saracino
Journal:  BMC Infect Dis       Date:  2020-03-06       Impact factor: 3.090

Review 2.  A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy.

Authors:  Cesare Mazzaro; Luca Quartuccio; Luigi Elio Adinolfi; Dario Roccatello; Gabriele Pozzato; Riccardo Nevola; Maurizio Tonizzo; Stefano Gitto; Pietro Andreone; Valter Gattei
Journal:  Viruses       Date:  2021-11-09       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.